CAROLINE BONNEMA: Open Payments
NPI 1962245167 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 45 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $376 · 2025 $1,004
Food & beverage: $911Education: $93
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 11 | $219 |
| ABBVIE INC. | 3 | $141 |
| Merck Sharp & Dohme LLC | 6 | $121 |
| AstraZeneca Pharmaceuticals LP | 3 | $78 |
| Gilead Sciences, Inc. | 3 | $63 |
| Eisai Inc. | 3 | $63 |
| Incyte Corporation | 2 | $56 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $32 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
Products named: REBLOZYL, KEYTRUDA, IMBRUVICA, Trodelvy, Lenvima, EPKINLY, ENHERTU, DATROWAY.
Industry payments across TX — which companies pay providers there.
